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Background: Recently we have reported 5 cases of allergic fungal cough (AFC), which is intrac-
table and is characterized by sensitization to one of basidiomycetous fungus. Because AFC
shows good clinical response to antifungal drugs, diagnosing AFC in patients with CIC may lead
to the consequent management of CIC. Therefore, we determined the incidence of CIC among
our hospital patients, and the frequency of BM fungi in sputum samples collected from
patients with CIC. Furthermore we evaluated whether or not a recognizable clinical pattern
that distinguishes CIC from non-CIC exists.
Methods: The medical records of 70 patients complaining of chronic cough who were referred
to our hospital for diagnosis and treatment were analyzed retrospectively.
Results: The primary diagnoses were CIC (27.0%), cough-variant asthma (30.0%), atopic cough
(24.3%), sinobronchial syndrome (8.6%), cough-predominant asthma (7.1%), gastro-esophageal
reflux (1.4%), and others (1.4%). In CIC patients, the median age, proportion of females, and
frequency of acute upper respiratory tract infection did not differ significantly from those
in non-CIC patients. CIC patients had a longer median duration of cough (11.0 months vs.
3.5 months). The positive ratio of BM cultured from the sputa of CIC patients (62.5%) was
significantly (pZ 0.0061) higher than that of non-CIC patients (16.7%).6 266 1060; fax: þ81 76 266 1070.
et.or.jp (H. Ogawa).
9 Elsevier Ltd. All rights reserved.
The importance of basidiomycetous fungi in CIC 1493Conclusion: The existence of BM fungi in induced sputum may be an important factor for
distinguishing the clinical manifestation of CIC from that of non-CIC. The clinical approach
from the aspect of fungal allergy may serve as a clue that may aid in the successful manage-
ment of CIC.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Cough is the most common complaint for which medical
attention is sought, and chronic cough can be both physi-
cally and mentally debilitating.
Despite extensive diagnostic evaluation and numerous
treatment guidelines,1e4 a number of patients remain
troubled by chronic and uncontrollable cough. Chronic
idiopathic cough (CIC)5,6 has been reported as a subgroup of
chronic coughers in whom a diagnosis cannot be made even
after thorough systematic investigation. Even though the
major causes of chronic cough exhibit geographical varia-
tion7,8 it is important to investigate how to manage chronic
intractable cough and how to address the problem of CIC
and minimize the diagnosis of CIC.
Recently, we proposed a new clinical disease concept
termed fungus-associated chronic cough (FACC),9 which
entailed the following manifestations: (1) chronic cough;
(2) the presence of environmental fungi, particularly
basidiomycetous (BM) fungi, in the sputum; and (3) good
clinical response to antifungal drugs.
Our previous study has revealed that FACC includes
another type of condition termed allergic fungal cough
(AFC),10 which is intractable and is characterized by
sensitization with Bjerkandera adusta (B. adusta), a type of
basidiomycetous (BM) fungus.
Because AFC shows good clinical response to antifungal
drugs, diagnosing AFC among patients diagnosed with CIC
may become the first step for the successful management
of chronic intractable cough patients, which will lead to the
consequent management of CIC.
To assess the usefulness of diagnosing AFC in patients
with CIC, we determined the incidence of CIC among our
hospital patients, and the frequency of BM fungi in sputum
samples collected from patients with CIC. Furthermore we
evaluated whether or not a recognizable clinical pattern
that distinguishes CIC from non-CIC exists.Methods
Patients
The medical records of 70 patients referred to Saiseikai
Kanazawa Hospital between June and December 2006 were
collected and reviewed retrospectively. All patients had
a cough of at least 8 week’s duration. Their referrals were
made not only by primary care physicians but also by
respiratory specialists. The following information was
collected from the medical records: name, date of birth,
gender, source of referral, duration of symptoms,
preceding acute upper respiratory tract infection (UTRI),
smoking habits, and results of fungal culture obtained fromnebulized hypertonic saline-induced sputum that was
collected from the patients at their first visit.
The cause of chronic cough in each patient was diagnosed
based on a questionnaire, blood examination findings, chest
and sinus X-rays, induced-sputum examination, pulmonary
function tests,11 test for cough reflex sensitivity to inhaled
capsaicin,12 bronchial reversibility in response to broncho-
dilators, bronchial responsiveness to methacholine,13 and
the efficacy of individual cause-specific treatments.
Capsaicin cough threshold was measured as an index of
airway cough reflex sensitivity according to the method
reported by the authors.12 The capsaicin cough threshold
was defined as the lowest concentration of inhaled capsa-
icin eliciting five or more coughs. Positive bronchial
reversibility was defined as percentage increase in FEV1
>12% and absolute increase in FEV1 >200 mL. The non-
specific bronchial responsiveness to methacholine was
assessed according to the method described by Cockcroft
et al.13 The results were expressed as the provocation
concentration (mg/mL) required to cause a 20% or more fall
from the baseline FEV1 (respiratory threshold of meth-
acholine; RT-Meth).
The examinations were performed in accordance with
the diagnostic criteria for each cause, as recommended by
the Japanese Cough Research Society1 and Japanese
Respiratory Society.2
Diagnostic criteria of chronic cough
The clinical features of atopic cough (AC)14e16 were consid-
ered to be as follows: (1) chronic bronchodilator-resistant
nonproductive cough with ‘‘tickle’’ in the throat lasting for
more than eight weeks; (2) absence of wheezing, dyspnea,
hemoptysis, or pleurisy, and no adventitious lung sounds on
physical examination; (3) presence of one or more global
atopic findings, including past history and/or complication of
allergic diseases except for bronchial asthma, family history
of allergic diseases, peripheral blood eosinophilia, elevated
total IgE level in the serum, positive specific IgE antibody to
common aeroallergens, and positive allergen skin test; (4)
presence of eosinophils in hypertonic saline-induced sputum
and/or submucosa of biopsied trachea and/or bronchi; (5)
normal limits of forced expiratory volume in 1 s (FEV1),
forced vital capacity (FVC), and FEV1/FVC ratio; (6) no
bronchial reversibility defined as less than a 5% increase in
FEV1 after inhalation of 300 mg salbutamol following 250 mg
aminophylline injection; (7) bronchial responsiveness within
normal limits; (8) increased airway cough reflex sensitivity;
and (9) complete relief of the cough upon treatment with
histamine H1 antagonists, inhaled corticosteroid therapy
and/or oral corticosteroid therapy.
Cough-variant asthma (CVA)17 was diagnosed based on the
following diagnostic criteria: (1) chronic nonproductive cough
1494 H. Ogawa et al.as an isolated symptom lasting for more than eight weeks; (2)
absence of a history of wheezing or dyspnea, and no adven-
titious lung sounds on physical examination; (3) absence of
PND to account for the cough; (4) normal limits of FEV1, FVC,
and FEV1/FVC ratio; (5) presence of bronchial hyper-respon-
siveness (RT-Meth< 10 mg/mL); (6) normal limits of cough
reflex sensitivity (C5> 3.9 mm); (7) no abnormal findings
indicative of cough aetiology on chest radiograph; and (8)
relief of cough with bronchodilator therapy. When all criteria
were satisfied, a definite diagnosis of CVA was made.
The patient was diagnosed with cough-predominant
asthma when the following criteria were satisfied: (1)
chronic cough as a sole manifestation; (2) no history of
wheezing or dyspnea attacks suggestive of asthma; (3) no
adventitious lung sounds on lung auscultation; (4) relief
from cough on bronchodilator therapy; and (5) presence of
one or more of the following findings that are specific to
bronchial asthma: (i) positive bronchial reversibility in
response to beta-2 agonists defined as increases in FEV1 of
>12% and >200 mL following inhalation of 300 mg salbuta-
mol sulfate and (ii) increased diurnal variation of peak flow
rate. Some researchers may diagnose such conditions as
cough-variant asthma whereas others, as bronchial asthma.
Sinobronchial syndrome (SBS)18 was diagnosed according
to the following diagnostic criteria: (1) productive cough
without wheezing lasting for eight weeks or more; (2) one or
more of the following findings: (i) symptoms such as post-
nasal drip (PND) and throat clearing; (ii) signs such as mucus
or mucopurulent secretion in the upper and middle pharynx,
and cobble stone appearance of the mucosa; (iii) fluid
retention or mucosal thickening on sinus X-ray or computed
tomographic (CT) scan; and (iv) increased neutrophils
without eosinophils in nasal secretions and spontaneous
sputum; (3) no atopic findings; (4) no bronchial reversibility;
(5) bronchial responsiveness within normal limits; (6) normal
limits of cough reflex sensitivity; and (7) relief of cough on
treatment with 14- or 15-member macrolides. The efficacy
of the treatment was evaluated at 2 months after the start
of treatment and was judged as effective when the
productive cough diminished to half or less. When all criteria
were satisfied, a definite diagnosis of SBS was made.
The specific treatments given before the diagnosis of CIC
was made were as follows. Suspected CVA17 was treated in
the first instance with b2-agonists (a combination of oral
40 mg/d clenbuterol and 200 mg salbutamol inhalation at
bedtime and on demand). If this proved insufficient,
treatment was stepped up according to the guidelines on
the treatment of asthma. Suspected AC,13 i.e., bronchodi-
lator-resistant cough (eosinophilic tracheobronchitis with
cough hypersensitivity), was treated with histamine H1
antagonists and inhaled corticosteroids (a combination of
10 mg/d cetrizine hydrochloride and 400e800 mg/d flutica-
sone propionate). Suspected SBS18 was treated with clari-
thromycin (oral 200 mg/d). Suspected GER4 was treated
with a high dose of proton-pump inhibitors. The duration of
each treatment was a minimum of 3 months.Mycological study
Induced-sputum samples obtained from the patients were
inoculated on Sabouraud’s dextrose agar (SDA) containingchloramphenicol. The morphological features of the strains
were recorded by a mycological specialist by using the slide
culture method (30 C for 2 weeks) and by staining with
lactophenol cotton blue.
Statistical analysis
Statistical analysis of quantitative data [age at referral, age
at onset of cough, duration of cough, and logarithmic
transformation of concentration causing 5 coughs (log C5)]
was performed using the ManneWhitney U test. Dichoto-
mous data (gender, previous URTI, and positive result of
cultured basidiomycetous BM fungi) were analyzed using
a c2 test. A p value of less than 0.05 was considered to be
statistically significant. The trial was approved by the
institutional review boards, and informed consent was
obtained from each of the 70 patients.
Results
Information was collected from a total of 70 consecutive
new patient referrals between June and December 2006.
The studied patients comprised 33 males and 37 females.
The median age of the patients at referral was 51 years
(range 22e80 years). The median duration of symptoms was
4.5 months (range 2e181 months). Chest X-rays were
normal for all the patients and mucosal thickness or
fluid collection of maxilla glands in sinus X-rays was
detected in 6 patients. Nine patients were current smokers,
and 14 patients were ex-smokers.
Chronic airflow limitation was considered present when
the ratio of FEV1 to FVC (FEV1/FVC ratio) was <0.7. An FEV1
of <80% of the predicted value was found in only three of
the 70 patients. Cough reflex sensitivity was increased in 29
patients. Bronchial responsiveness to methacholine was
exaggerated in five patients.
The bronchodilator therapy showed effectiveness in
26 patients (21 CVA patients and 5 cough-predominant
asthma patients) but not in the other 44 patients. The
therapy of histamine H1 antagonists and inhaled cortico-
steroids produced a clinical response in 17 patients with AC.
A cause for the cough was identified in 51 patients. In
the remaining 19 patients, no cause was found and there-
fore a diagnosis of CIC was given. The primary diagnoses
were CIC (27.1%), CVA (30.0%), AC (24.3%), SBS (8.6%),
cough-predominant asthma (7.1%), GER (1.4%), and others
(1.4%) (Table 1).
The characteristics of the 19 patients with CIC were
compared with 51 patients with non-CIC in whom another
diagnosis had been assigned (Table 2). The CIC patients had
a median age of 59 years (range, 22e80 years), and 42.1%
were female. The respective values for the non-CIC
patients were 51 years (range, 22e78 years) and 56.9%.
None of the characteristics were different between the
2 groups. The median duration of cough in the CIC group
was 24 months (range, 8e180 months), which was longer
compared with 12 months (range, 8e120 months) in the
non-CIC group (pZ 0.0292). The capsaicin challenge results
were available for 19 CIC patients (100%) and 47 non-CIC
patients (92.2%). A significant difference in the cough
sensitivity was found between the 2 groups (pZ 0.0292).
Table 1 Primary diagnosis of the causes of chronic cough.
Primary diagnosis Number
of
patients
CIC 19
Non-CIC Cough-variant asthma 21
Atopic cough 17
Sinobronchial syndrome 6
Cough-predominant asthma 5
Others GER 1
Psychogenic 1
Total 70
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patients are summarized in Table 3a. Positive results of the
sputum culture for BM were obtained in 10 of the 16 CIC
patients (62.5%) and in 3 of the 18 non-CIC patients (16.7%);
and the frequencies were significantly different
(pZ 0.0061) (Table 3b).
Discussion
Despite extensive diagnostic evaluation and numerous
treatment guidelines,1e4 a number of patients remain
troubled by chronic and uncontrollable cough. Though
asthmatic cough, gastro-esophageal reflux (GER)-associ-
ated cough, and postnasal drip (PND)-induced cough are
recognized as major causes of chronic cough in western
countries,4 GER-associated cough and PND-induced cough
are very rare in Japan.7,8 Recently a prospective multi-
center study revealed that atopic cough (AC), cough-
variant asthma (CVA), and sinobronchial syndrome (SBS) are
major causes of chronic cough in Japan.7
Diagnosing patients with intractable cough as having
CIC5,6 limits the management of disease in such patients;
therefore, it is important to investigate how to appropri-
ately address this problem and minimize the diagnosis of
CIC, even if the major causes of chronic cough exhibit
geographical variation.
Haque et al.5 reported the median duration of CIC to be
72 months, but this duration ranges from 8 to 324 months.
Therefore, it may be difficult to identify CIC as a homoge-
nous clinical entity. Therefore, it is fascinating to investi-
gate the CIC from a new perspective. Here, we explain the
importance of environmental fungi such as BM fungi inTable 2 Comparison of the characteristics between CIC and no
Variables CIC
Median age, yr 59 (22e80)
Gender, male:female 11:08
Median duration of cough, mo 24 (8e720)
Preceded by URTI, yes:no 2:10
Median C5 (solution number) 3 (1e8)
Median PC20 (mg/mL) 20 (5e20)
Median FEV1/FVC ratio 82 (60e100)
Median reversibility 24 (3.6 to 17.4investigating the disease in patients with chronic intrac-
table cough.
There have been an increasing number of studies con-
cerning the relationship between intractable allergic
diseases and environmental fungi and these studies have
attracted attention in the fields of otolaryngology19 and
dermatology.20 However, these studies have been limited
to allergic bronchopulmonary aspergillosis (ABPA)21 and
trichophyton-sensitized asthma22 in the field of respirology.
We have previously reported cases of AC caused by
a hypersensitivity to Trichosporon asahii,23 Pichia guillier-
mondii,24 Streptomyces albus,25 and also reported the first
case of nonasthmatic sputum eosinophilia caused by
allergic reaction to a BM fungus (originally mislabeled as
Humicola fuscoatra) in which the increase of eosinophils in
the induced-sputum was established by repeated environ-
mental surveys to be closely related to the appearance of
BM fungi in the patient’s house.26 Furthermore, we have
reported several cases of AC which were sensitized with BM
fungi and successfully eradicated and treated with low-
dose itraconazole27 or oral cleansing with amphotericin B.28
Although only a limited number of the literature has
documented infectious diseases caused by BM fungi, such as
Schizophyllum commune,29 the Coprinus species,30 much of
the literature reports the possible role of basidiospores as
airborne allergens.31,32
From the results of our series of studies on patients with
fungus-associated atopic cough,23e26 we have focused on
the possible role of BM as a fungal aeroallergen. Initially we
performed pharyngeal swab cultures for the detection of
fungi in 141 patients with chronic nonproductive cough and
identified Candida and BM in 10.6% and 6.4% of all the
examined patients, respectively.33 Since BM fungi are rarely
detected in the culture of pharyngeal swabs taken from
non-coughers,34 and the positive ratio of the immediate
subcutaneous reaction for BM fungi in allergic airway
diseases such as atopic cough (AC), cough-variant asthma
(CVA), and cough-predominant asthma was significantly
higher than that in non-coughers (unpublished data), we
suspected that the positive culture results were not caused
by an environmental fungal contamination. Therefore, we
have hypothesized that BM fungi colonizing in the pharynx
or lower respiratory tract plays an important role in allergic
airway disorders.
Aspergillus is well known to be the cause of eumycetes.
When culturing sputum for detection of eumycetes, it
should be noted that although it requires only approxi-
mately 2 days for detecting Aspergillus, approximately 10n-CIC patients.
Non-CIC p Value
51 (22e78) 0.2673
22:29 0.0714
12 (8e480) 0.0292
3:37 0.3448
4 (2e8) 0.0292
10 (0.078e20) 0.0416
80 (71e99) 0.9999
) 24 (6.5 to 15.2) 0.5381
Table 3a The frequencies of positive sputum culture for
all fungi in 34 patients with chronic cough.
Basidiomycetous fungi 13
Candida albicans 9
Aspergillus fumigatus 5
Penicillium 5
Aspergillus niger 3
Aspergillus flavus 1
1496 H. Ogawa et al.days are required for culturing BM. During the 10th annual
meeting of the Japan Cough Research Society, it was found
that several laboratories store the nutrient medium only for
approximately 2 days. This renders the detection of BM
impossible in the institutions that discard the culture
medium after 2 days.
Thus, we proposed a new clinical disease concept
termed fungus-associated chronic cough (FACC),9 which
entailed the following manifestations: (1) chronic cough;
(2) the presence of environmental fungi, particularly
basidiomycetous (BM) fungi, in the sputum; and (3) good
clinical response to antifungal drugs. Because FACC shows
clinical response to antifungal drugs, the participation in
planning of the antifungal drugs may become a new
attractive strategy in the treatment of chronic cough.
Our previous study has revealed that allergic fungal
cough (AFC) is a type of FACC.10 AFC is intractable and is
characterized by sensitization with B. adusta, which is
a basidiomycetous fungus. The clinical features in the 5
patients in our hospital diagnosed with AFC are as follows:
(1) chronic intractable cough with a tickling sensation and
a feeling of something being stuck in their throats, lasting
for more than 8 weeks; (2) the presence of environmental
fungi such as BM fungus, particularly, B. adusta, in the
sputum; (3) positive reactions to inhalation bronchoprovo-
cation test and/or lymphocyte stimulation test to the
fungus; (4) clinical response to antifungal drugs requiring
long duration (more than approximately 10 weeks) for
complete remission of cough symptoms; and (5) frequent
recurrence of cough.
If the new disease concept of AFC had not been
devised, the clusters of 5 patients would have been
diagnosed with chronic idiopathic cough (CIC). On theTable 3b The frequencies of positive sputum culture for
BM fungi in 34 patients with chronic cough.
Primary diagnosis Obtained
sampling
no.
BM
positive
no.
CIC 16 10
Non-CIC Cough-variant asthma 8 1
Atopic cough 6 2
Sinobronchial syndrome 3 0
Cough-predominant asthma 1 0
Others GER 0 0
Psychogenic 0 0basis of these experiences, we investigated these patients
for the clinical manifestations of AFC before diagnosing
these patients with CIC. To assess the usefulness of
diagnosing AFC in patients with CIC, we determined the
incidence of CIC among our hospital patients, and the
frequency of BM fungi in sputum samples collected from
patients with CIC. We also determined whether or not
a recognizable clinical pattern that distinguishes CIC from
non-CIC exists.
In this study, a diagnosis could not be achieved in 19
patients (27.1%); these patients were therefore assigned to
CIC according to the Japanese Cough Research Society,1
Japanese Respiratory Society,2 and the American College of
Chest Physicians (ACCP) evidence-based practice guide-
lines.4 The results of this study conducted in our hospital
demonstrate that CIC is not a rare condition. Except for the
median duration, none of the clinical characteristics
significantly differed between the CIC and the non-CIC
patients. CIC patients had a significantly higher cough
reflex sensitivity in response to capsaicin and lower bron-
chial responsiveness as compared to non-CIC patients.
These results can be explained by the fact that the patients
with non-CIC exhibited a relatively high incidence of
increased bronchial responsiveness exhibited by conditions
such as CVA and cough-predominant asthma and relatively
low incidence of increased cough reflex sensitivity exhibi-
ted by conditions such as AC and GER. In other words,
asthmatic cough, such as CVA and cough-predominant
asthma, does not seem to be frequently encountered in
patients with CIC.
It is remarkable that BM fungi were the most common
species among the fungi identified in the sputum samples
obtained from CIC patients and that the positive ratio of BM
cultured from the sputa of CIC patients was significantly
(pZ 0.0061) higher than that of non-CIC patients.
From these findings, the existence of BM fungi in induced
sputum may be one of the important factors to distinguish
the clinical manifestation of CIC from that of non-CIC.
Therefore, detecting BM fungi from the expectoration of
the CIC patients may become a clue that leads to a part of
success in the management of CIC.Conflict of interest
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